Free Trial

Venus Concept (VERO) Competitors

Venus Concept logo
$2.52 0.00 (0.00%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$2.53 +0.01 (+0.40%)
As of 08/1/2025 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VERO vs. BDMD, XAIR, DHAI, MHUA, INBS, LYRA, BTCY, PAVM, LUCY, and CODX

Should you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Baird Medical Investment (BDMD), Beyond Air (XAIR), DIH Holding US (DHAI), Meihua International Medical Technologies (MHUA), Intelligent Bio Solutions (INBS), Lyra Therapeutics (LYRA), Biotricity (BTCY), PAVmed (PAVM), Innovative Eyewear (LUCY), and Co-Diagnostics (CODX). These companies are all part of the "medical equipment" industry.

Venus Concept vs. Its Competitors

Baird Medical Investment (NASDAQ:BDMD) and Venus Concept (NASDAQ:VERO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

19.8% of Baird Medical Investment shares are held by institutional investors. Comparatively, 87.4% of Venus Concept shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by company insiders. Comparatively, 28.0% of Venus Concept shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Baird Medical Investment has a beta of -0.99, suggesting that its share price is 199% less volatile than the S&P 500. Comparatively, Venus Concept has a beta of 0.12, suggesting that its share price is 88% less volatile than the S&P 500.

In the previous week, Venus Concept had 1 more articles in the media than Baird Medical Investment. MarketBeat recorded 1 mentions for Venus Concept and 0 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.00 equaled Venus Concept'saverage media sentiment score.

Company Overall Sentiment
Baird Medical Investment Neutral
Venus Concept Neutral

Baird Medical Investment has higher earnings, but lower revenue than Venus Concept.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baird Medical InvestmentN/AN/AN/AN/AN/A
Venus Concept$64.83M0.06-$47M-$76.30-0.03

Baird Medical Investment has a net margin of 0.00% compared to Venus Concept's net margin of -81.26%. Baird Medical Investment's return on equity of 0.00% beat Venus Concept's return on equity.

Company Net Margins Return on Equity Return on Assets
Baird Medical InvestmentN/A N/A N/A
Venus Concept -81.26%-752.29%-54.52%

Summary

Baird Medical Investment and Venus Concept tied by winning 4 of the 8 factors compared between the two stocks.

Get Venus Concept News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VERO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERO vs. The Competition

MetricVenus ConceptMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$3.59M$6.77B$5.47B$9.53B
Dividend YieldN/A1.32%4.74%4.08%
P/E Ratio-0.0320.9428.6723.80
Price / Sales0.0659.01422.3188.12
Price / CashN/A20.5035.4557.96
Price / Book0.594.468.275.55
Net Income-$47M$174.54M$3.24B$259.03M
7 Day Performance-2.33%-5.27%-3.63%-4.56%
1 Month Performance-14.58%-3.94%4.40%4.49%
1 Year Performance-67.74%8.26%25.97%18.05%

Venus Concept Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERO
Venus Concept
1.294 of 5 stars
$2.52
flat
N/A-66.2%$3.59M$64.83M-0.03410Gap Up
BDMD
Baird Medical Investment
N/A$2.10
flat
N/AN/A$13.82MN/A0.00N/AGap Down
XAIR
Beyond Air
3.6802 of 5 stars
$3.17
-1.1%
$23.67
+647.8%
-74.0%$13.72M$3.70M-0.2070Short Interest ↑
DHAI
DIH Holding US
0.5848 of 5 stars
$0.27
+0.7%
N/A-91.5%$12.88M$64.47M-0.91N/ANews Coverage
MHUA
Meihua International Medical Technologies
1.6085 of 5 stars
$0.40
+3.0%
N/A-59.9%$12.86M$96.90M0.00620
INBS
Intelligent Bio Solutions
0.5622 of 5 stars
$1.53
-0.3%
N/A+9.7%$10.54M$3.11M0.0010
LYRA
Lyra Therapeutics
2.9764 of 5 stars
$7.79
-0.2%
$100.00
+1,184.5%
-57.0%$10.32M$1.19M-0.1350Positive News
BTCY
Biotricity
N/A$0.40
-17.4%
N/A-40.4%$9.97M$12.06M-0.3740Gap Up
High Trading Volume
PAVM
PAVmed
4.4264 of 5 stars
$0.58
+0.7%
$19.00
+3,204.3%
-34.5%$9.83M$2.99M0.8190News Coverage
Positive News
LUCY
Innovative Eyewear
0.0928 of 5 stars
$2.14
+1.9%
N/A-52.2%$9.72M$1.64M-0.539Positive News
CODX
Co-Diagnostics
3.7739 of 5 stars
$0.28
-0.2%
$5.50
+1,885.6%
-77.6%$9.30M$3.91M-0.24100News Coverage
Positive News
Upcoming Earnings
Short Interest ↑

Related Companies and Tools


This page (NASDAQ:VERO) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners